Dihexa is an angiotensin-IV-derived peptidomimetic investigated primarily in preclinical neuroscience research. Published work has examined its interaction with the hepatocyte growth factor (HGF)/c-Met system and potential effects on synaptic plasticity and cognition, but Dihexa itself does not have an FDA-approved human therapeutic use or an established clinical dosing regimen.
The scientifically defensible answer depends on the desired laboratory concentration and the quantity of material being investigated.
There is no single universal BAC-water volume for Dihexa. The amount of liquid used in a mathematical concentration calculation determines the concentration expressed in mg/mL. Changing the liquid volume changes the concentration calculation; it does not change the total mass of Dihexa represented by the starting material.
| Example material quantity | 1 mL | 2 mL | 2.5 mL | 3 mL | 5 mL |
|---|---|---|---|---|---|
| 1 mg | 1 mg/mL | 0.5 mg/mL | 0.4 mg/mL | 0.33 mg/mL | 0.2 mg/mL |
| 5 mg | 5 mg/mL | 2.5 mg/mL | 2 mg/mL | 1.67 mg/mL | 1 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 4 mg/mL | 3.33 mg/mL | 2 mg/mL |
| 20 mg | 20 mg/mL | 10 mg/mL | 8 mg/mL | 6.67 mg/mL | 4 mg/mL |
These rows are mathematical examples and are not claims that the listed quantities are standardized commercial Dihexa vial sizes.
Use the BacScience universal calculator for custom mathematical concentration calculations.
No authoritative Dihexa-specific reconstitution instruction was identified that establishes a universal BAC-water volume.
A 5 mg quantity would mathematically correspond to 5 mg/mL at a 1 mL liquid volume, 2.5 mg/mL at 2 mL, 2 mg/mL at 2.5 mL, and 1 mg/mL at 5 mL.
These are arithmetic concentration outcomes, not recommended preparation volumes.
A 10 mg quantity would mathematically correspond to 10 mg/mL at 1 mL, 5 mg/mL at 2 mL, 4 mg/mL at 2.5 mL, 3.33 mg/mL at 3 mL, and 2 mg/mL at 5 mL.
Again, these values describe concentration only and should not be interpreted as dosing instructions.
If the starting mass stays constant, increasing the liquid volume decreases the concentration. Decreasing the liquid volume increases the concentration. The underlying relationship is simply:
This relationship is independent of whether the calculation is being performed for Dihexa or another compound. What is compound-specific is whether a particular solvent, formulation, concentration range, stability condition, or administration route has actually been validated.
Dihexa is also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide. FDA's Substance Registration System lists Dihexa with the molecular formula C27H44N4O5 and a molecular weight of approximately 504.66 g/mol.
The FDA substance record also lists Dihexa under the identifiers ATH-1001 and PNB-0408 and associates it with CAS 1401708-83-5.
Dihexa is generally discussed in the scientific literature as an angiotensin-IV-derived peptidomimetic with activity related to the hepatocyte growth factor/c-Met signaling system.
Research has focused on mechanisms involving synaptogenesis, neuronal signaling, and cognition, primarily in experimental models.
Preclinical research has proposed that Dihexa interacts with hepatocyte growth factor (HGF) and influences signaling through the c-Met receptor system.
A 2014 study reported that Dihexa binds HGF with high affinity and can augment HGF-dependent c-Met phosphorylation. The same work reported effects on hippocampal spinogenesis and synaptogenesis in experimental systems. :contentReference[oaicite:2]{index=2}
These observations provide a biological rationale for further research, but they should not be interpreted as evidence that Dihexa is an established cognitive treatment in humans.
Experimental research has examined whether Dihexa can influence synaptic formation and neuronal signaling through the HGF/c-Met system. :contentReference[oaicite:3]{index=3}
Animal research has investigated Dihexa-related effects in models of learning and memory. A review of the HGF/c-Met system describes Dihexa as a compound of interest in experimental Alzheimer's disease research. :contentReference[oaicite:4]{index=4}
No clinically established human therapeutic use or human dosing regimen for Dihexa was identified in the authoritative sources reviewed for this page.
Importantly, this should not be confused with research involving related compounds or derivatives. The existence of human studies of another molecule does not establish Dihexa as safe, effective, or clinically dosed.
A compound can have substantial mechanistic or animal literature while still lacking the clinical evidence required for an approved human treatment.
Therefore, preclinical observations involving Dihexa should remain classified as preclinical evidence rather than clinical evidence.
This section deliberately does not convert experimental research concentrations or animal exposure levels into human dosing advice.
| Evidence type | Model | Research focus | Interpretation |
|---|---|---|---|
| In vitro | Cellular / biochemical systems | HGF binding and c-Met signaling | Mechanistic evidence |
| Animal | Rodent cognitive models | Learning, memory and synaptic effects | Preclinical evidence |
| Human | No established clinical regimen identified | No established therapeutic indication | Insufficient for clinical dosing recommendations |
Reconstitution and concentration are related concepts, but they should not be treated as evidence that a particular solvent or volume has been validated for Dihexa.
For a simple mass-per-volume calculation:
If a laboratory sample contains 10 mg of material and the calculation uses 2 mL of liquid, the resulting mathematical concentration is 5 mg/mL.
If the same 10 mg quantity is represented using 5 mL, the mathematical concentration is 2 mg/mL.
Nothing about the arithmetic establishes that either volume is an appropriate Dihexa formulation or administration method.
When the starting quantity stays constant, increasing the liquid volume increases the denominator in the concentration equation. The resulting numerical concentration therefore decreases.
When the starting quantity stays constant, decreasing the liquid volume decreases the denominator. The resulting numerical concentration therefore increases.
Mathematical concentration does not establish solubility, stability, sterility, compatibility, biological activity, or suitability for administration. Those questions require compound-specific laboratory validation.
Enter your own quantity and liquid volume in the universal BacScience calculator.
Dihexa is not an FDA-approved human therapeutic. FDA records identify Dihexa as a chemical substance, while FDA enforcement and compounding materials have specifically discussed Dihexa in the context of unapproved drug substances.
FDA has also identified potential safety concerns associated with compounded drugs containing Dihexa, including potential immunogenicity concerns for certain routes related to aggregation or peptide-related impurities. :contentReference[oaicite:5]{index=5}
Online research-compound protocols can mix mathematical concentration, experimental animal dosing, and anecdotal human use. These categories are not interchangeable.
A mathematical calculation can establish mg/mL. It cannot establish whether a compound should be administered to a person.
Much of the Dihexa literature concerns laboratory and animal models. Preclinical activity involving HGF/c-Met signaling does not establish efficacy or safety for human cognitive disorders.
| Evidence category | Status | What it means |
|---|---|---|
| FDA-approved human use | No | No FDA-approved indication identified for Dihexa. |
| Human therapeutic dose | Not established | No clinically established human dose identified. |
| Mechanistic research | Yes | HGF/c-Met and related cellular mechanisms have been investigated. |
| Animal research | Yes | Experimental cognitive and synaptic effects have been studied. |
| Validated BAC-water protocol | Not established | No universal Dihexa-specific reconstitution volume should be assumed. |
Dihexa is an angiotensin-IV-derived peptidomimetic investigated in preclinical neuroscience research, particularly around HGF/c-Met signaling, synaptic plasticity and cognition.
No. Dihexa does not have an FDA-approved human therapeutic indication.
No universal scientifically established BAC-water volume for Dihexa was identified. A liquid volume changes the mathematical concentration, but it does not establish a validated formulation.
Concentration in mg/mL is calculated by dividing the total quantity in milligrams by the liquid volume in milliliters.
No. In a simple concentration calculation, adding more liquid does not change the starting mass; it changes the amount of material per milliliter.
This page does not treat any particular commercial vial quantity as a scientifically established Dihexa standard. Commercial or research-supplier packaging should be verified independently.
No clinically established human dose has been identified. Preclinical research quantities must not be converted into human treatment recommendations.
Experimental studies have investigated effects involving HGF/c-Met signaling, synaptogenesis, neuronal signaling and cognitive performance in laboratory models.
Preclinical literature describes Dihexa as a blood-brain-barrier penetrant compound. This property is part of its research interest and does not establish clinical effectiveness in humans.
Yes. The BacScience universal calculator can perform the underlying quantity-versus-volume concentration mathematics using custom values.
No. Mathematical concentration, experimental research exposure and clinically established dosing are different concepts.
Start with primary literature and authoritative databases such as PubMed, FDA substance records and peer-reviewed research rather than vendor protocols or community dosing claims.
Calculate concentration from a custom compound quantity and liquid volume.
Explore additional educational resources covering research compounds and laboratory concepts.
Browse research-focused educational material covering peptide chemistry and concentration concepts.
Developer note: replace this URL if the site's current BAC-water resource hub uses a different Shopify handle.
Primary and authoritative sources used to establish the scientific context of this page.